Average Co-Inventor Count = 3.71
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Xenon Pharmaceuticals Inc. (21 from 109 patents)
2. Novartis Ag (9 from 3,923 patents)
3. Signalchem Lifesciences Corporation (7 from 8 patents)
4. Kinetek Pharmaceuticals, Inc. (6 from 6 patents)
5. Qlt Inc. (4 from 35 patents)
6. Dermira (canada), Inc. (3 from 6 patents)
7. Valocor Therapeutics, Inc. (2 from 2 patents)
8. Angiotech Pharmaceuticals, Inc. (1 from 15 patents)
9. Dirmira (canada), Inc. (1 from 1 patent)
10. Olt Inc. (1 from 1 patent)
11. Dermira, Inc. (15 patents)
12. Novartis Pharma Gmbh (8 patents)
50 patents:
1. 12097194 - Combination therapy for treating blood cancer
2. 11034685 - Aminopyridine derivatives as TAM family kinase inhibitors
3. 11034686 - Aminopyridine derivatives as TAM family kinase inhibitors
4. 10723725 - Aminopyridine derivatives as TAM family kinase inhibitors
5. 10562859 - Aryl sulfonamide compounds as carbonic anhydrase inhibitors and their therapeutic use
6. 10233176 - Aminopyridine derivatives as TAM family kinase inhibitors
7. 9771333 - Quinazoline derivatives as TAM family kinase inhibitors
8. 9630929 - Benzenesulfonamide compounds and their use as therapeutic agents
9. 9481677 - Biaryl ether sulfonamides and their use as therapeutic agents
10. 9434720 - Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
11. 9187426 - Organic compounds
12. 8754233 - Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
13. 8541457 - Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors
14. 8501746 - Organic compounds
15. 8445694 - Hydrazonopyrazole derivatives and their use as therapeutics